Literature DB >> 12849748

X11alpha modulates secretory and endocytic trafficking and metabolism of amyloid precursor protein: mutational analysis of the YENPTY sequence.

G D King1, R G Perez, M L Steinhilb, J R Gaut, R S Turner.   

Abstract

The neuronal adaptor X11alpha interacts with the conserved -GYENPTY- sequence in the C-terminus of amyloid precursor protein (APP) or its Swedish mutation (APPswe) to inhibit Abeta40 and Abeta42 secretion. We hypothesized that the -YENP- motif essential for APP endocytosis is also essential for X11alpha-mediated effects on APP trafficking and metabolism, and that X11alpha modulates APP metabolism in both secretory and endocytic pathways. X11alpha failed to interact with the endocytic-defective APPswe mutants Y738A, N740A, or P741A, and thus did not modulate their trafficking or metabolism. However, endocytic-competent APPswe Y743A had unique trafficking and metabolism including a prolonged half-life and increased secretion of catabolites compared with APPswe. In contrast to endocytic-defective mutants, X11alpha interacted with APPswe Y743A as well as with APPswe. Thus, similar to APPswe, coexpression of X11alpha with APPswe Y743A retarded its maturation, prolonged its half-life, and inhibited APPs, Abeta40, and Abeta42 secretion. Collectively, these data suggest that by direct interaction with the APPswe -YENP- motif in the cytoplasmic tail, X11alpha modulated its trafficking and processing in both secretory and endocytic compartments, and may reduce secretion of Abeta generated in either pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12849748     DOI: 10.1016/s0306-4522(03)00284-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  Mint3/X11gamma is an ADP-ribosylation factor-dependent adaptor that regulates the traffic of the Alzheimer's Precursor protein from the trans-Golgi network.

Authors:  Punya Shrivastava-Ranjan; Victor Faundez; Guofu Fang; Howard Rees; James J Lah; Allan I Levey; Richard A Kahn
Journal:  Mol Biol Cell       Date:  2007-10-24       Impact factor: 4.138

Review 2.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

3.  X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice.

Authors:  Inderjeet Saluja; Henry Paulson; Ashwin Gupta; R Scott Turner
Journal:  Neurobiol Dis       Date:  2009-07-23       Impact factor: 5.996

4.  Scaffold protein X11α interacts with kalirin-7 in dendrites and recruits it to Golgi outposts.

Authors:  Kelly A Jones; Andrew G Eng; Pooja Raval; Deepak P Srivastava; Peter Penzes
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

5.  Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint.

Authors:  James Ashley; Mary Packard; Bulent Ataman; Vivian Budnik
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

6.  beta-Secretase inhibitor potency is decreased by aberrant beta-cleavage location of the "Swedish mutant" amyloid precursor protein.

Authors:  Hidekuni Yamakawa; Sosuke Yagishita; Eugene Futai; Shoichi Ishiura
Journal:  J Biol Chem       Date:  2009-11-19       Impact factor: 5.157

7.  Role of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in Drosophila.

Authors:  Garrett G Gross; R M Renny Feldman; Atish Ganguly; Jinhui Wang; Hong Yu; Ming Guo
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

8.  Targeting the APP-Mint2 Protein-Protein Interaction with a Peptide-Based Inhibitor Reduces Amyloid-β Formation.

Authors:  Christian R O Bartling; Thomas M T Jensen; Shawna M Henry; Anna L Colliander; Vita Sereikaite; Marcella Wenzler; Palash Jain; Hans M Maric; Kasper Harpsøe; Søren W Pedersen; Louise S Clemmensen; Linda M Haugaard-Kedström; David E Gloriam; Angela Ho; Kristian Strømgaard
Journal:  J Am Chem Soc       Date:  2021-01-05       Impact factor: 15.419

9.  Numb and Alzheimer's disease: the current picture.

Authors:  Dimitrios Ntelios; Benedikt Berninger; Georgios Tzimagiorgis
Journal:  Front Neurosci       Date:  2012-10-04       Impact factor: 4.677

10.  RNAi-mediated knock-down of Dab and Numb attenuate Aβ levels via γ-secretase mediated APP processing.

Authors:  Zhongcong Xie; Yuanlin Dong; Uta Maeda; Weiming Xia; Rudolph E Tanzi
Journal:  Transl Neurodegener       Date:  2012-03-22       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.